Found: 16
Select item for more details and to access through your institution.
Unmet Needs, Quality of Life, and Financial Toxicity Among Survivors of Lung Cancer.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 4, p. e246872, doi. 10.1001/jamanetworkopen.2024.6872
- By:
- Publication type:
- Article
An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive Analysis.
- Published in:
- Current Oncology, 2022, v. 29, n. 6, p. 4342, doi. 10.3390/curroncol29060347
- By:
- Publication type:
- Article
Druggable genomic landscapes of high-grade gliomas.
- Published in:
- Frontiers in Medicine, 2023, p. 1, doi. 10.3389/fmed.2023.1254955
- By:
- Publication type:
- Article
Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer.
- Published in:
- BioDrugs, 2023, v. 37, n. 6, p. 775, doi. 10.1007/s40259-023-00614-5
- By:
- Publication type:
- Article
Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer Immunotherapy.
- Published in:
- Oncologist, 2022, v. 27, n. 11, p. 971, doi. 10.1093/oncolo/oyac140
- By:
- Publication type:
- Article
A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy‐Naïve Advanced or Metastatic Nonsquamous Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 7, p. 859, doi. 10.1634/theoncologist.2017-0465
- By:
- Publication type:
- Article
Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade.
- Published in:
- Oncologist, 2017, v. 22, n. 6, p. 627, doi. 10.1634/theoncologist.2016-0390
- By:
- Publication type:
- Article
Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Sex-specific differences in immunogenomic features of response to immune checkpoint blockade.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.945798
- By:
- Publication type:
- Article
Case Report: Hematologic Recovery Following Stereotactic Ablative Radiotherapy in a Patient With Early-Stage Non-Small Cell Lung Cancer and Paraneoplastic Myelofibrosis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.842620
- By:
- Publication type:
- Article
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/Gastroesophageal Adenocarcinoma.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 4, p. 175
- By:
- Publication type:
- Article
Using Immune Checkpoint Inhibitors in Lung Cancer... includes discussion.
- Published in:
- Oncology (08909091), 2016, v. 30, n. 8, p. 713
- By:
- Publication type:
- Article
Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion Diagnostics.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 5321, doi. 10.2147/OTT.S273357
- By:
- Publication type:
- Article
Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy.
- Published in:
- Journal of Neurosurgery, 2022, v. 136, n. 1, p. 56, doi. 10.3171/2020.10.JNS201787
- By:
- Publication type:
- Article
Current challenges of hematologic complications due to immune checkpoint blockade: a comprehensive review.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 1, p. 1, doi. 10.1007/s00277-021-04690-x
- By:
- Publication type:
- Article